메뉴 건너뛰기




Volumn 117, Issue 19, 2011, Pages 4424-4438

Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and autophagy

Author keywords

ARHI; autophagy; decitabine; imprinted tumor suppressor genes; ovarian cancer; PEG3; suberoylanilide hydroxamic acid

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; AZACITIDINE; TRICHOSTATIN A; VORINOSTAT;

EID: 80052927231     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26073     Document Type: Article
Times cited : (128)

References (40)
  • 3
    • 67649440886 scopus 로고    scopus 로고
    • The biology of ovarian cancer: New opportunities for translation
    • Bast RC Jr, Hennessy B, Mills GB,. The biology of ovarian cancer: new opportunities for translation. Nat Rev Cancer. 2009; 9: 415-428.
    • (2009) Nat Rev Cancer. , vol.9 , pp. 415-428
    • Bast, Jr.R.C.1    Hennessy, B.2    Mills, G.B.3
  • 4
    • 33644846509 scopus 로고    scopus 로고
    • Epigenetic gene silencing in cancer - A mechanism for early oncogenic pathway addiction?
    • DOI 10.1038/nrc1799, PII N1799
    • Baylin SB, Ohm JE,. Epigenetic gene silencing in cancer-a mechanism for early oncogenic pathway addiction? Nat Rev Cancer. 2006; 6: 107-116. (Pubitemid 43361543)
    • (2006) Nature Reviews Cancer , vol.6 , Issue.2 , pp. 107-116
    • Baylin, S.B.1    Ohm, J.E.2
  • 5
    • 0036274359 scopus 로고    scopus 로고
    • The fundamental role of epigenetic events in cancer
    • Jones PA, Baylin SB,. The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002; 3: 415-428. (Pubitemid 34587077)
    • (2002) Nature Reviews Genetics , vol.3 , Issue.6 , pp. 415-428
    • Jones, P.A.1    Baylin, S.B.2
  • 6
    • 34250213859 scopus 로고    scopus 로고
    • DNA methylation as a therapeutic target in cancer
    • Issa JP,. DNA methylation as a therapeutic target in cancer. Clin Cancer Res. 2007; 13: 1634-1637.
    • (2007) Clin Cancer Res. , vol.13 , pp. 1634-1637
    • Issa, J.P.1
  • 8
    • 80052922810 scopus 로고    scopus 로고
    • A phase IB-IIA study to reverse platinum resistance by use of a hypomethylating agent azacitidine in platinum-resistant or refractory epithelial ovarian
    • In press.
    • Fu S, Hu W, Iyer R, et al. A phase IB-IIA study to reverse platinum resistance by use of a hypomethylating agent azacitidine in platinum-resistant or refractory epithelial ovarian Cancer. In press.
    • Cancer.
    • Fu, S.1    Hu, W.2    Iyer, R.3
  • 9
    • 36048958965 scopus 로고    scopus 로고
    • Histone deacetylase inhibitors: Overview and perspectives
    • DOI 10.1158/1541-7786.MCR-07-0324
    • Dokmanovic M, Clarke C, Marks PA,. Histone deacetylase inhibitors: overview and perspectives. Mol Cancer Res. 2007; 5: 981-989. (Pubitemid 350080267)
    • (2007) Molecular Cancer Research , vol.5 , Issue.10 , pp. 981-989
    • Dokmanovic, M.1    Clarke, C.2    Marks, P.A.3
  • 10
    • 33644814867 scopus 로고    scopus 로고
    • Selective induction of apoptosis by histone deacetylase inhibitor SAHA in cutaneous T-cell lymphoma cells: Relevance to mechanism of therapeutic action
    • Zhang C, Richon V, Ni X, Talpur R, Duvic M,. Selective induction of apoptosis by histone deacetylase inhibitor SAHA in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action. J Invest Dermatol. 2005; 125: 1045-1052.
    • (2005) J Invest Dermatol. , vol.125 , pp. 1045-1052
    • Zhang, C.1    Richon, V.2    Ni, X.3    Talpur, R.4    Duvic, M.5
  • 11
    • 43049091153 scopus 로고    scopus 로고
    • A phase II study of vorinostat in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: A Gynecologic Oncology Group study
    • Modesitt SC, Sill M, Hoffman JS, Bender DP,. A phase II study of vorinostat in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2008; 109: 182-186.
    • (2008) Gynecol Oncol. , vol.109 , pp. 182-186
    • Modesitt, S.C.1    Sill, M.2    Hoffman, J.S.3    Bender, D.P.4
  • 12
    • 34250651294 scopus 로고    scopus 로고
    • Histone deacetylase inhibitors of demethylating agents: Clinical development of histone deacetylase inhibitors for cancer therapy
    • Piekarz RL, Sackett DL, Bates SE,. Histone deacetylase inhibitors of demethylating agents: clinical development of histone deacetylase inhibitors for cancer therapy. Cancer J. 2007; 13: 30-39.
    • (2007) Cancer J. , vol.13 , pp. 30-39
    • Piekarz, R.L.1    Sackett, D.L.2    Bates, S.E.3
  • 13
    • 33750530675 scopus 로고    scopus 로고
    • Phase 1/2 study of the combination of 5-aza-2′-deoxycytidine with valproic acid in patients with leukemia
    • Garcia-Manero G, Kantarjian HM, Sanchez-Gonzolez B, et al. Phase 1/2 study of the combination of 5-aza-2′-deoxycytidine with valproic acid in patients with leukemia. Blood. 2006; 108: 3271-3279.
    • (2006) Blood. , vol.108 , pp. 3271-3279
    • Garcia-Manero, G.1    Kantarjian, H.M.2    Sanchez-Gonzolez, B.3
  • 15
    • 5144231704 scopus 로고    scopus 로고
    • WAF1/CIP1 and prolonged progression-free survival
    • DOI 10.1158/1078-0432.CCR-04-0698
    • Rosen DG, Wang L, Jain AJ, et al. Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival. Clin Cancer Res. 2004; 10: 6559-6566. (Pubitemid 39346551)
    • (2004) Clinical Cancer Research , vol.10 , Issue.19 , pp. 6559-6566
    • Rosen, D.G.1    Wang, L.2    Jain, A.N.3    Lu, K.H.4    Luo, R.Z.5    Yu, Y.6    Liu, J.7    Bast Jr., R.C.8
  • 16
    • 41149093072 scopus 로고    scopus 로고
    • Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation
    • DOI 10.1002/cncr.23323
    • Feng W, Marquez RT, Lu Z, et al. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter mehtylation. Cancer. 2008; 112: 1489-1502. (Pubitemid 351441161)
    • (2008) Cancer , vol.112 , Issue.7 , pp. 1489-1502
    • Feng, W.1    Marquez, R.T.2    Lu, Z.3    Liu, J.4    Lu, K.H.5    Issa, J.-P.J.6    Fishman, D.M.7    Yu, Y.8    Bast Jr., R.C.9
  • 17
    • 33646411738 scopus 로고    scopus 로고
    • Transcriptional and posttranscriptional down-regulation of the imprinted tumor suppressor gene ARHI (DRAS3) in ovarian cancer
    • Lu Z, Luo RZ, Peng H, et al. Transcriptional and posttranscriptional down-regulation of the imprinted tumor suppressor gene ARHI (DRAS3) in ovarian cancer. Clin Cancer Res. 2006; 12: 2404-2413.
    • (2006) Clin Cancer Res. , vol.12 , pp. 2404-2413
    • Lu, Z.1    Luo, R.Z.2    Peng, H.3
  • 19
    • 57449121645 scopus 로고    scopus 로고
    • A Ras-related imprinted tumor suppressor gene ARHI regulates autophagy and tumor dormancy in ovarian cancer
    • Lu Z, Luo RZ, Lu Y, et al. A Ras-related imprinted tumor suppressor gene ARHI regulates autophagy and tumor dormancy in ovarian cancer. J Clin Invest. 2008; 118: 3917-3929.
    • (2008) J Clin Invest. , vol.118 , pp. 3917-3929
    • Lu, Z.1    Luo, R.Z.2    Lu, Y.3
  • 20
    • 12944308330 scopus 로고    scopus 로고
    • Eating oneself and uninvited guests: Autophagy-related pathways in cellular defense
    • DOI 10.1016/j.cell.2005.01.005, PII S0092867405000437
    • Levine B,. Eating oneself and uninvited guests: autophagy-related pathways in cellular defense. Cell. 2005; 120: 159-162. (Pubitemid 40174758)
    • (2005) Cell , vol.120 , Issue.2 , pp. 159-162
    • Levine, B.1
  • 21
    • 22744459936 scopus 로고    scopus 로고
    • A new simple and high-yield synthesis of suberoylanilide hydroxamic acid and its inhibitory effect alone or in combination with retinoids on proliferation of human prostate cancer cells
    • DOI 10.1021/jm058214k
    • Gediya LK, Chopra P, Purushottamachar P, Maheshwari N, Njar VC,. A new simple and high-yield synthesis of suberoylanilide hydroxamic acid and its inhibitory effect alone or in combination with retinoids on proliferation of human prostate cancer cells. J Med Chem. 2005; 48: 5047-5051. (Pubitemid 41033145)
    • (2005) Journal of Medicinal Chemistry , vol.48 , Issue.15 , pp. 5047-5051
    • Gediya, L.K.1    Chopra, P.2    Purushottamachar, P.3    Maheshwari, N.4    Njar, V.C.O.5
  • 23
    • 0002658306 scopus 로고
    • The median-effect principle and the combination index for quantification of synergism and antagonism
    • Chou T.C. Rideout D.C. eds. San Diego, CA: Academic Press.
    • Chou TC,. The median-effect principle and the combination index for quantification of synergism and antagonism. In:, Chou TC, Rideout DC, eds. Synergism and Antagonism in Chemotherapy. San Diego, CA: Academic Press; 1991: 61-101.
    • (1991) Synergism and Antagonism in Chemotherapy , pp. 61-101
    • Chou, T.C.1
  • 24
    • 0013886333 scopus 로고
    • Evaluation of survival data and 2 new rank order statistics arising in its consideration
    • Mantel N,. Evaluation of survival data and 2 new rank order statistics arising in its consideration. Cancer Chemotherapy Rep. 1966; 50: 163-170.
    • (1966) Cancer Chemotherapy Rep. , vol.50 , pp. 163-170
    • Mantel, N.1
  • 25
    • 84950651862 scopus 로고
    • The efficiency of Cox's likelihood function for censored data
    • Efron B,. The efficiency of Cox's likelihood function for censored data. JASA. 1977; 72: 557-565.
    • (1977) JASA , vol.72 , pp. 557-565
    • Efron, B.1
  • 26
    • 33748794547 scopus 로고    scopus 로고
    • Theoretical basis, experimental design, and computerized simulation and antagonism in drug combination studies
    • Chou TC,. Theoretical basis, experimental design, and computerized simulation and antagonism in drug combination studies. Pharmacol Rev. 2006; 58: 621-681.
    • (2006) Pharmacol Rev. , vol.58 , pp. 621-681
    • Chou, T.C.1
  • 27
    • 20344394418 scopus 로고    scopus 로고
    • Antileukemia activity of the combination of 5-aza-2′-deoxycytidine with valproic acid
    • DOI 10.1016/j.leukres.2004.11.022, PII S014521260500038X
    • Yang H, Hoshino K, Sanchez-Gonzolez B, Kantarjian H, Garcia-Manero G,. Antileukemia activity of the combination of 5-aza-2′-deoxycytidine with valproic acid. Leuk Res. 2005; 29: 739-748. (Pubitemid 40779480)
    • (2005) Leukemia Research , vol.29 , Issue.7 , pp. 739-748
    • Yang, H.1    Hoshino, K.2    Sanchez-Gonzalez, B.3    Kantarjian, H.4    Garcia-Manero, G.5
  • 28
    • 33746679765 scopus 로고    scopus 로고
    • Effect of histone deacetylase inhibitor LAQ824 on antineoplastic action of 5-Aza-2′-deoxycytidine (decitabine) on human breast carcinoma cells
    • DOI 10.1007/s00280-006-0225-6
    • Hurtubise A, Momparler RL,. Effect of histone deacetylase inhibitor LAQ824 on antineoplastic action of 5-aza-2′-deoxycytidine on human breast carcinoma cells. Cancer Chemother Pharmacol. 2006; 58: 618-625. (Pubitemid 44167387)
    • (2006) Cancer Chemotherapy and Pharmacology , vol.58 , Issue.5 , pp. 618-625
    • Hurtubise, A.1    Momparler, R.L.2
  • 29
    • 34250661469 scopus 로고    scopus 로고
    • DNA demethylating agents and histone deacetylase inhibitors in hematologic malignancies
    • Fandy TE, Carraway H, Gore SD,. DNA demethylating agents and histone deacetylase inhibitors in hematologic malignancies. Cancer J. 2007; 13: 40-48.
    • (2007) Cancer J. , vol.13 , pp. 40-48
    • Fandy, T.E.1    Carraway, H.2    Gore, S.D.3
  • 31
    • 58749100626 scopus 로고    scopus 로고
    • Azacitidine enhances sensitivity of platinum-resistant ovarian cancer cells to carboplatin through induction of apoptosis
    • Li Y, Hu W, Shen DY, Kavanagh JJ, Fu S,. Azacitidine enhances sensitivity of platinum-resistant ovarian cancer cells to carboplatin through induction of apoptosis. Am J Obstet Gynecol. 2009; 200: 177.e1-177.e9.
    • (2009) Am J Obstet Gynecol. , vol.200
    • Li, Y.1    Hu, W.2    Shen, D.Y.3    Kavanagh, J.J.4    Fu, S.5
  • 32
    • 33847130464 scopus 로고    scopus 로고
    • Comparative evaluation of the treatment efficacy of suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer cell lines and primary ovarian cancer cells from patients [serial online
    • Sonnemann J, Gange J, Pitz S, et al. Comparative evaluation of the treatment efficacy of suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer cell lines and primary ovarian cancer cells from patients [serial online. BMC Cancer. 2006; 6: 183.
    • (2006) BMC Cancer. , vol.6 , pp. 183
    • Sonnemann, J.1    Gange, J.2    Pitz, S.3
  • 33
    • 70749118328 scopus 로고    scopus 로고
    • Suberoylanilide hydroxamic acid (SAHA) potentiates paclitaxel-induced apoptosis in ovarian cancer cell lines
    • Dietrich CS, 3rd, Greenberg VL, DeSimone CP, et al. Suberoylanilide hydroxamic acid (SAHA) potentiates paclitaxel-induced apoptosis in ovarian cancer cell lines. Gynecol Oncol. 2010; 116: 126-130.
    • (2010) Gynecol Oncol. , vol.116 , pp. 126-130
    • Dietrich III, C.S.1    Greenberg, V.L.2    Desimone, C.P.3
  • 34
    • 61749093379 scopus 로고    scopus 로고
    • Combined inhibition of DNA methylation and histone acetylation enhances gene re-expression and drug sensitivity in vivo
    • Steele N, Finn P, Brown R, Plumb JA,. Combined inhibition of DNA methylation and histone acetylation enhances gene re-expression and drug sensitivity in vivo. Br J Cancer. 2009; 100: 758-763.
    • (2009) Br J Cancer. , vol.100 , pp. 758-763
    • Steele, N.1    Finn, P.2    Brown, R.3    Plumb, J.A.4
  • 35
    • 39749155114 scopus 로고    scopus 로고
    • Pharmacokinetics of decitabine administered as a 3-h infusion to patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS)
    • DOI 10.1007/s00280-007-0531-7
    • Cashen AF, Shah AK, Todt L, Fisher N, DiPeriso J,. Pharmacokinetics of decitabine administered as a 3-hour infusion to patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). Cancer Chemother Pharmacol. 2008; 61: 759-766. (Pubitemid 351302031)
    • (2008) Cancer Chemotherapy and Pharmacology , vol.61 , Issue.5 , pp. 759-766
    • Cashen, A.F.1    Shah, A.K.2    Todt, L.3    Fisher, N.4    DiPersio, J.5
  • 36
    • 17444452612 scopus 로고    scopus 로고
    • Low-dose 5-Aza-2'-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: A multicenter phase II study in elderly patients
    • Wijermans P, Lubbert M, Verhoef G, et al. Low-dose 5-aza-2′- deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: a multicenter phase II study in elderly patients. J Clin Oncol. 2000; 18: 956-962. (Pubitemid 30123770)
    • (2000) Journal of Clinical Oncology , vol.18 , Issue.5 , pp. 956-962
    • Wijermans, P.1    Lubbert, M.2    Verhoef, G.3    Bosly, A.4    Ravoet, C.5    Andre, M.6    Ferrant, A.7
  • 38
    • 33847609658 scopus 로고    scopus 로고
    • Identification of candidate methylation-responsive genes in ovarian cancer [serial online
    • Menendez L, Walker D, Matyunia LV, et al. Identification of candidate methylation-responsive genes in ovarian cancer [serial online. Mol Cancer. 2007; 6: 10.
    • (2007) Mol Cancer. , vol.6 , pp. 10
    • Menendez, L.1    Walker, D.2    Matyunia, L.V.3
  • 39
    • 59449088943 scopus 로고    scopus 로고
    • Treatment of ovarian cancer cell lines with 5-aza-2 deoxycytidine up-regulates the expression of cancer-testis antigens and class i major histocompatibility complex-encoded molecules
    • Adair SJ, Hogan KT,. Treatment of ovarian cancer cell lines with 5-aza-2 deoxycytidine up-regulates the expression of cancer-testis antigens and class I major histocompatibility complex-encoded molecules. Cancer Immunol. 2009; 58: 589-601.
    • (2009) Cancer Immunol. , vol.58 , pp. 589-601
    • Adair, S.J.1    Hogan, K.T.2
  • 40
    • 77956525903 scopus 로고    scopus 로고
    • Genomewide DNA methylation analysis reveals novel targets for drug development in mantel cell lymphoma
    • Leshchenko VV, Kuo P-Y, Shaknovich R, et al. Genomewide DNA methylation analysis reveals novel targets for drug development in mantel cell lymphoma. Blood. 2010; 116: 1025-1034.
    • (2010) Blood. , vol.116 , pp. 1025-1034
    • Leshchenko, V.V.1    Kuo, P.-Y.2    Shaknovich, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.